{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:59:57Z","timestamp":1771880397312,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","urologypracticejournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology Practice"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.urpr.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T21:15:58Z","timestamp":1488489358000},"page":"132-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Gu\u00e9rin Treatment"],"prefix":"10.1097","volume":"5","author":[{"given":"Andrew T.","family":"Lenis","sequence":"first","affiliation":[{"name":"Department of Urology, Health Services Research Group, Los Angeles, California"},{"name":"Jonsson Comprehensive Cancer Center, Los Angeles, California"},{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kian","family":"Asanad","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Blaibel","sequence":"additional","affiliation":[{"name":"University of California, Riverside School of Medicine, Riverside, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas M.","family":"Donin","sequence":"additional","affiliation":[{"name":"Department of Urology, Health Services Research Group, Los Angeles, California"},{"name":"Jonsson Comprehensive Cancer Center, Los Angeles, California"},{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Chamie","sequence":"additional","affiliation":[{"name":"Department of Urology, Health Services Research Group, Los Angeles, California"},{"name":"Jonsson Comprehensive Cancer Center, Los Angeles, California"},{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.urpr.2017.02.012_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"suppl.","key":"10.1016\/j.urpr.2017.02.012_bib2","first-page":"S199","article-title":"The management of BCG failure in non-muscle-invasive bladder cancer: an update","volume":"3","author":"Zlotta","year":"2009","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urpr.2017.02.012_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.eururo.2014.11.031","article-title":"Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Gu\u00e9rin","volume":"67","author":"Mostafid","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urpr.2017.02.012_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eururo.2013.07.021","volume":"65","author":"Brausi","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urpr.2017.02.012_bib6","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urpr.2017.02.012_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/iju.12644","article-title":"Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review","volume":"22","author":"Cantiello","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.urpr.2017.02.012_bib8","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.urpr.2017.02.012_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/ATVBAHA.107.151092","article-title":"Metabolic syndrome pandemic","volume":"28","author":"Grundy","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.urpr.2017.02.012_bib10","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.7314\/APJCP.2013.14.5.3117","article-title":"Obesity and risk of bladder cancer: a meta-analysis of cohort studies","volume":"14","author":"Qin","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.urpr.2017.02.012_bib11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ije\/dyv001","article-title":"Metabolic risk score and cancer risk: pooled analysis of seven cohorts","volume":"44","author":"Stocks","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.urpr.2017.02.012_bib12","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/ATVBAHA.111.241869","article-title":"Metabolic syndrome, insulin resistance, and roles of inflammation\u2013mechanisms and therapeutic targets","volume":"32","author":"Romeo","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.urpr.2017.02.012_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2013a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urpr.2017.02.012_bib14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.urolonc.2009.07.020","article-title":"Bladder cancer in the elderly","volume":"27","author":"Shariat","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urpr.2017.02.012_bib15","first-page":"1634","article-title":"The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy","volume":"175","author":"Joudi","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urpr.2017.02.012_bib16","first-page":"1124","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urpr.2017.02.012_bib17","first-page":"480","article-title":"Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder","volume":"190","author":"Kluth","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urpr.2017.02.012_bib18","first-page":"1283","article-title":"Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer","volume":"177","author":"Raj","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urpr.2017.02.012_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.urolonc.2014.08.016","article-title":"Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer","volume":"33","author":"Chamie","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urpr.2017.02.012_bib20","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/ijc.25521","article-title":"Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can)","volume":"128","author":"H\u00e4ggstr\u00f6m","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urpr.2017.02.012_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.urpr.2017.02.012_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cncr.28394","article-title":"Body mass and smoking are modifiable risk factors for recurrent bladder cancer","volume":"120","author":"Wyszynski","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.urpr.2017.02.012_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2011.06096.x","article-title":"The growing challenge of obesity and cancer: an inflammatory issue","volume":"1229","author":"Harvey","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.urpr.2017.02.012_bib24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.300.13.1523","article-title":"Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk","volume":"300","author":"Kaklamani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.urpr.2017.02.012_bib25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.urpr.2017.02.012_bib26","first-page":"194","article-title":"Smoking-related genitourinary cancers: a global call to action in smoking cessation","volume":"18","author":"Gottlieb","year":"2016","journal-title":"Rev Urol"}],"container-title":["Urology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352077917300456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352077917300456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.urpr.2017.02.012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:44:37Z","timestamp":1651211077000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.urpr.2017.02.012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1016\/j.urpr.2017.02.012"],"URL":"https:\/\/doi.org\/10.1016\/j.urpr.2017.02.012","relation":{},"ISSN":["2352-0779"],"issn-type":[{"value":"2352-0779","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Gu\u00e9rin Treatment","name":"articletitle","label":"Article Title"},{"value":"Urology Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urpr.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by American Urological Association Education and Research, Inc.","name":"copyright","label":"Copyright"}]}}